|Articles|May 5, 2017
SGS Announces Results of H3N2 Influenza Trial
SGS announced the successful completion of a Phase I clinical trial of a new strain of influenza virus in healthy volunteers.
Advertisement
SGS announced the successful completion of a Phase I clinical trial of a new strain of influenza virus in healthy volunteers. The agent is approved for use as a challenge agent in studies demonstrating the early efficacy of influenza drugs and vaccines.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research
2
When AI Learns to Speak Every Language: An eCOA Migration Study
3
Using Digital Tools to Enhance Patient-Centric Trials
4
Gilead’s ARTISTRY-2 Trial Shows Bictegravir Lenacapavir Combo Matches Biktarvy in Virologically Suppressed Adults With HIV
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
